S Post1,2, D Rozeveld1,2, M R Jonker1,2, R Bischoff3, A J van Oosterhout1,2, I H Heijink1,2,4. 1. Department of Pathology & Medical Biology, Experimental Pulmonology and Inflammation Research, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. 2. GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. 3. Department of Pharmacy, Analytical Biochemistry, University of Groningen, Groningen, The Netherlands. 4. Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Abstract
BACKGROUND: House dust mite (HDM) acts on the airway epithelium to induce airway inflammation in asthma. We previously showed that the ability of HDM to induce allergic sensitization in mice is related to airway epithelial CCL20 secretion. OBJECTIVE: As a disintegrin and metalloprotease (ADAM)s have been implicated in chemokine shedding, we sought to determine their involvement in HDM-induced release of chemokines, including CCL20, by airway epithelial cells. METHODS: We studied the effects of pharmacological ADAM inhibitors as well as ADAM10 and ADAM17 siRNA downregulation on chemokine release using (multiplex) ELISA in supernatants from HDM-exposed human bronchial epithelial 16HBE cells and primary normal human bronchial epithelial cells (NHBE) at 4-24 h. RESULTS: House dust) mite markedly increased CCL20 levels in both 16HBE and NHBE cells (16-24 h). In 16HBE cells, the HDM-induced increase was observed as early as 4 h upon exposure and the use of specific inhibitors indicated the involvement of ADAM10/17-mediated shedding. siRNA knockdown of ADAM10, but not of ADAM17, significantly reduced the HDM-induced release of CCL20 in both 16HBE and NHBE cells. A similar effect was observed for HDM-induced CCL2, CCL5, and CXCL8 release in NHBE cells. The HDM-induced increase in CCL20 levels was not affected by protein synthesis inhibitor cycloheximide nor protein transport inhibitor monensin, indicating that HDM induces surface shedding of chemokines. CONCLUSION: Our data show for the first time that ADAM10 activity contributes to HDM-induced shedding of chemokines, including CCL20. The ADAM10/CCL20 axis may be a target for novel therapeutic strategies in asthma.
BACKGROUND: House dust mite (HDM) acts on the airway epithelium to induce airway inflammation in asthma. We previously showed that the ability of HDM to induce allergic sensitization in mice is related to airway epithelial CCL20 secretion. OBJECTIVE: As a disintegrin and metalloprotease (ADAM)s have been implicated in chemokine shedding, we sought to determine their involvement in HDM-induced release of chemokines, including CCL20, by airway epithelial cells. METHODS: We studied the effects of pharmacological ADAM inhibitors as well as ADAM10 and ADAM17 siRNA downregulation on chemokine release using (multiplex) ELISA in supernatants from HDM-exposed human bronchial epithelial 16HBE cells and primary normal human bronchial epithelial cells (NHBE) at 4-24 h. RESULTS: House dust) mite markedly increased CCL20 levels in both 16HBE and NHBE cells (16-24 h). In 16HBE cells, the HDM-induced increase was observed as early as 4 h upon exposure and the use of specific inhibitors indicated the involvement of ADAM10/17-mediated shedding. siRNA knockdown of ADAM10, but not of ADAM17, significantly reduced the HDM-induced release of CCL20 in both 16HBE and NHBE cells. A similar effect was observed for HDM-induced CCL2, CCL5, and CXCL8 release in NHBE cells. The HDM-induced increase in CCL20 levels was not affected by protein synthesis inhibitor cycloheximide nor protein transport inhibitor monensin, indicating that HDM induces surface shedding of chemokines. CONCLUSION: Our data show for the first time that ADAM10 activity contributes to HDM-induced shedding of chemokines, including CCL20. The ADAM10/CCL20 axis may be a target for novel therapeutic strategies in asthma.
Authors: Jalahalli M Siddesha; Emily M Nakada; Bethany R Mihavics; Sidra M Hoffman; Gurkiranjit K Rattu; Nicolas Chamberlain; Jonathon M Cahoon; Karolyn G Lahue; Nirav Daphtary; Minara Aliyeva; David G Chapman; Dhimant H Desai; Matthew E Poynter; Vikas Anathy Journal: Am J Physiol Lung Cell Mol Physiol Date: 2016-05-06 Impact factor: 5.464
Authors: Jihui Zhang; Jie Chen; Jonathan P Richardson; Nicola-Jane Francis-Newton; Pei F Lai; Kerry Jenkins; Meriel R Major; Rebekah E Key; Mark E Stewart; Stuart Firth-Clark; Steven M Lloyd; Gary K Newton; Trevor R Perrior; David R Garrod; Clive Robinson Journal: ACS Pharmacol Transl Sci Date: 2022-08-12
Authors: Virinchi N S Kuchibhotla; Marnix R Jonker; Harold G de Bruin; Jacobien A Noordhoek; Darryl A Knight; Martijn C Nawijn; Irene H Heijink Journal: Allergy Date: 2020-02-24 Impact factor: 13.146
Authors: M Loxham; D E Smart; N J Bedke; N P Smithers; I Filippi; C Blume; E J Swindle; K Tariq; P H Howarth; S T Holgate; D E Davies Journal: Mucosal Immunol Date: 2017-07-05 Impact factor: 7.313
Authors: Ayşe Kılıç; Asher Ameli; Jin-Ah Park; Alvin T Kho; Kelan Tantisira; Marc Santolini; Feixiong Cheng; Jennifer A Mitchel; Maureen McGill; Michael J O'Sullivan; Margherita De Marzio; Amitabh Sharma; Scott H Randell; Jeffrey M Drazen; Jeffrey J Fredberg; Scott T Weiss Journal: Sci Rep Date: 2020-01-22 Impact factor: 4.379
Authors: Irene H Heijink; Virinchi N S Kuchibhotla; Mirjam P Roffel; Tania Maes; Darryl A Knight; Ian Sayers; Martijn C Nawijn Journal: Allergy Date: 2020-06-16 Impact factor: 13.146